1. Medtech Insight
  2. >>Policy & Regulation

Medtronic’s 780G – Finally! – Gets FDA Approval

 
• By Barnaby Pickering

Earlier than expected, but still after a more than three year wait, the company has obtained FDA approval for its flagship insulin delivery system.  

After a long wait, Medtronic has received US Food and Drug Administration approval for its MiniMed 780G insulin pump, in combination with its Guardian 4 continuous glucose monitor, the company announced on April 21.

The company can now start selling its system to the more than 1.4 million type I diabetics in the US, provided they are seven years old or older.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.